CD4 and infection: It is also of interest that recent human trials examining BCG revaccination or M. tuberculosis protein subunit vaccines H4/IC31 or M72/AS01E, all of which predominantly stimulate CD4+ T- lymphocyte responses, demonstrated a significant level of protection against sustained infection (46, 47).